Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-18T01:29:06.089Z Has data issue: false hasContentIssue false
  • English
  • Français

Fibromyalgia Syndrome: Diagnosis and Comorbidities

Published online by Cambridge University Press:  07 November 2014

Benjamin H. Natelson
Get access Rights & Permissions [Opens in a new window]

Extract

In 1990, The American College of Rheumatology laid out several sets of criteria for the diagnosis of fibromyalgia syndrome (FM). The first criterion required patients to report at least 3 months of widespread pain. Pain was considered widespread if it was present in four quadrants of the body—the right and left side as well as above and below the waist. Axial skeleton pain is also very commonly present in FM and is often considered a fifth “quadrant.” The second diagnostic criterion was widespread pain in response to a tender point examination. In this assessment the clinician presses on 18 specific areas with enough pressure to blanche his fingertip (∼4 kg). The patient's report of pain and not pressure on such testing in at least 11 of the tender points completes the requirements for the diagnosis of FM (Slide 1). Although these criteria were established to standardize patients for research studies, many physicians follow them for diagnostic purposes as well. However, these criteria must be viewed in the same context as the definition of hypertension (ie, blood pressures ≥140/90). Patients who do not quite attain these criteria should still be considered to have probable hypertension; and the same applies to FM. A patient who has three-quadrant pain and 9 tender points does not meet the criteria for FM, but the therapeutic approach to this patient is the same as it is for the patient with definitive FM.

Type
Expert Review Supplement
Information
CNS Spectrums , Volume 14 , Issue S8: Clinical Case Update in Fibromyalgia Management , October 2009 , pp. 8 - 11
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Wolfe, F, Smythe, HA, Yunus, MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of FM. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–172.CrossRefGoogle Scholar
2.Plesh, O, Wolfe, F, Lane, N. The relationship between FM and temporomandibular disorders: prevalence and symptom severity. J Rheumatol. 1996;23(11):1948–1952.Google ScholarPubMed
3.Lundberg, G, Gerdle, B. Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of FM syndrome. Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of FM syndrome. J Rheumatol. 2001;29:603.Google Scholar
4.White, KP, Thompson, J, Wolfe, . FM syndrome in an Amish community: a controlled study to determine disease and symptom prevalence. J Rheumatol. 2003;30(8):1835–1840.Google Scholar
5.Wolfe, F, Petri, M, Alarcón, GS, et al. FM, systemic lupus erythematosus (SLE), and evaluation of SLE activity. J Rheumatol. 2009;36(1):82–88.CrossRefGoogle ScholarPubMed
6.Wolfe, F, Ross, K, Anderson, J, Russell, IJ, Hebert, L. The prevalence and characteristics of FM in the general population. Arthritis Rheum. 1995;38(1):19–28.CrossRefGoogle Scholar
7.Kosek, E, Hansson, P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in FM patients and healthy subjects. Pain. 1997;70(1):41–51.CrossRefGoogle ScholarPubMed
8.Gracely, RH, Petzke, F, Wolf, JM, Clauw, DJ. Functional magnetic resonance imaging evidence of augmented pain processing in FM. Arthritis Rheum. 2002;46(5):1333–1343.CrossRefGoogle Scholar
9.Bennett, RM, Jones, J, Turk, DC, Russell, IJ, Matallana, L. An internet survey of 2,596 people with FM. BMC Musculoskelet Disord. 2007;8:27.CrossRefGoogle Scholar
10.Clauw, DJ, Crofford, LJ. Chronic widespread pain and FM: what we know, and what we need to know. Best Pract Res Clin Rheumatol. 2003;17(4):685–701.CrossRefGoogle ScholarPubMed
11.Goldenberg, DL. FM syndrome a decade later: what have we learned? Arch Intern Med. 1999;159(8):777–785.CrossRefGoogle Scholar
12.Wolfe, F, Michaud, K. Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize ra patients with FM. J Rheumatol. 2004;31(4):695–700.Google Scholar
13.Togo, F, Natelson, BH, Cherniack, NS, FitzGibbons, J, Garcon, C, Rappoport, DM. Sleep structure and sleepiness in chronic fatigue syndrome with or without co-existing FM. Arth Res Ther. 2008;10(3):R56.CrossRefGoogle ScholarPubMed
14.Caro, XJ, Winter, EF, Dumas, AJ. A subset of FM patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford). 2008;47(2):208–211.CrossRefGoogle Scholar